Table 1.
Demographics and clinical characteristics of study patients
| Total (n = 303) | |
|---|---|
| Age, year, mean (SD) | 72.29 ± 10.33 |
| Gender (male), n (%) | 180 (59.4) |
| Smoking status, n (%) | |
| Nonsmokers | 213 (70.3) |
| Former smokers | 39 (12.9) |
| Current smokers | 51 (16.8) |
| History of drinking, n (%) | 92 (30.4) |
| Hypertension, n (%) | 244 (80.5) |
| Diabetes, n (%) | 91 (30.0) |
| History of stroke or TIA, n (%) | 49 (16.2) |
| NIHSS, median (IQR) | 8 (3.15) |
| Infarction size, n (%) | |
| Small | 39 (12.9) |
| Medium | 122 (40.3) |
| Large | 142 (46.9) |
| Hemorrhagic transformation, n (%) | 112 (36.96) |
| Intravenous thrombolysis or arterial intervention, n (%) | 56 (18.5) |
| Antithrombotic drugs at discharge, n (%) | |
| None | 55 (18.2) |
| Antiplatelet | 85 (28.1) |
| Anticoagulant | 163 (53.8) |
Abbreviations: SD, standard deviation; IQR, inter quartile range; TIA, transient ischemic attack; NIHSS, National Institutes of Health Stroke Scale.